# Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)

> **NCT02762617** · PHASE1 · TERMINATED · sponsor: **Marla Keller** · enrollment: 17 (actual)

## Conditions studied

- Healthy
- HIV

## Interventions

- **DRUG:** Tenofovir disoproxil fumarate intravaginal ring
- **DRUG:** Placebo intravaginal ring (IVR)

## Key facts

- **NCT ID:** NCT02762617
- **Lead sponsor:** Marla Keller
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-24
- **Primary completion:** 2017-10-17
- **Final completion:** 2017-10-17
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Safety-related
- **Last updated:** 2018-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762617, "Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02762617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*